WEIGAO GROUP (01066) has announced that the company's board of directors was informed by its controlling shareholder, WEIGAO Group Co., Ltd., that based on recognition of the company's long-term investment value, confidence in the prospects of China's economic growth, and the medical device industry, WEIGAO Group purchased a total of 3.55 million H shares of the company in the open market on May 13, 2026, and May 14, 2026, using its own funds. This represents approximately 0.08% of the company's total issued H shares and total issued share capital, respectively.

Following this increase in holdings, as of the date of this announcement, WEIGAO Group collectively holds approximately 2.103 billion H shares of the company, representing about 46.51% of the company's total issued H shares and 46.02% of the company's total issued share capital.

According to WEIGAO Group, it is fully confident in the future development prospects of the group and does not rule out the possibility of considering further increases in the company's shareholdings at an appropriate time, subject to applicable laws and regulations.